Remus Pharmaceuticals Statistics

Total Valuation

NSE:REMUS has a market cap or net worth of INR 12.08 billion. The enterprise value is 12.05 billion.

Market Cap	12.08B
Enterprise Value	12.05B

Important Dates

The next estimated earnings date is Friday, February 7, 2025.

Earnings Date	Feb 7, 2025
Ex-Dividend Date	Nov 19, 2024

Share Statistics

NSE:REMUS has 5.89 million shares outstanding. The number of shares has increased by 8.32% in one year.

Current Share Class	n/a
Shares Outstanding	5.89M
Shares Change (YoY)	+8.32%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	52.29%
Owned by Institutions (%)	n/a
Float	2.76M

Valuation Ratios

The trailing PE ratio is 40.41.

PE Ratio	40.41
Forward PE	n/a
PS Ratio	2.65
PB Ratio	12.02
P/TBV Ratio	13.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	40.30
EV / Sales	2.64
EV / EBITDA	28.40
EV / EBIT	29.10
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.17.

Current Ratio	1.82
Quick Ratio	1.12
Debt / Equity	0.17
Debt / EBITDA	0.52
Debt / FCF	n/a
Interest Coverage	36.41

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	30.89%
Revenue Per Employee	95.10M
Profits Per Employee	6.23M
Employee Count	48
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.02% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+38.02%
50-Day Moving Average	2,387.74
200-Day Moving Average	2,274.87
Relative Strength Index (RSI)	39.33
Average Volume (20 Days)	3,418

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:REMUS had revenue of INR 4.57 billion and earned 299.01 million in profits. Earnings per share was 50.73.

Revenue	4.57B
Gross Profit	738.12M
Operating Income	392.45M
Pretax Income	458.53M
Net Income	299.01M
EBITDA	402.67M
EBIT	392.45M
Earnings Per Share (EPS)	50.73

Full Income Statement

Balance Sheet

The company has 459.93 million in cash and 208.45 million in debt, giving a net cash position of 251.48 million or 42.68 per share.

Cash & Cash Equivalents	459.93M
Total Debt	208.45M
Net Cash	251.48M
Net Cash Per Share	42.68
Equity (Book Value)	1.23B
Book Value Per Share	170.55
Working Capital	769.59M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 16.17%, with operating and profit margins of 8.60% and 6.55%.

Gross Margin	16.17%
Operating Margin	8.60%
Pretax Margin	10.04%
Profit Margin	6.55%
EBITDA Margin	8.82%
EBIT Margin	8.60%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.10%.

Dividend Per Share	2.00
Dividend Yield	0.10%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	-8.32%
Shareholder Yield	-8.22%
Earnings Yield	2.48%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on June 6, 2024. It was a forward split with a ratio of 4.

Last Split Date	Jun 6, 2024
Split Type	Forward
Split Ratio	4

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a